Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Therachon

Therachon?uq=UG6efJS6
2014 FOUNDED
PRIVATE STATUS
Mezzanine LATEST DEAL TYPE
$60M LATEST DEAL AMOUNT
8 INVESTORS
Description

Operator of a biotechnology firm intended to develop medicines for rare, genetic diseases that currently have no available treatments. The company develops a novel protein therapy in development for achondroplasia, the common form of short-limbed dwarfism, enabling patients and caregivers to avail medical services that can transform the lives of people with unmet medical needs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Aeschenvorstadt 36
  • 4051 Basel
  • Switzerland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Therachon’s full profile, request a free trial.

Therachon Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Mezzanine 09-Aug-2018 $60M 00000 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 05-Jan-2017 0000 0000 Completed Startup
2. Secondary Transaction - Private Completed Startup
1. Seed Round 01-Jan-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Therachon Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 09-Oct-2018 000000000000000000 Biotechnology 0000 0000000000 00
To view this company’s complete investment and acquisition history, request access »

Therachon Subsidiaries (1)

Company Name Industry Location Founded
000000000 Biotechnology Montreal, Canada 0000
To view this company’s complete subsidiary history, request access »

Therachon Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
Pfizer Ventures Venture Capital Minority 000 0000 000000 0
Tekla Capital Management Investment Bank Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Therachon Executive Team (9)

Name Title Board
Seat
Contact
Info
Luca Santarelli MD Co-Founder, Chief Executive Officer & Board Member
Richard Porter Ph.D Chief Operating Officer
Aled Williams Chief Commercial Officer and Head of Patient Access
Elvire Gouze Ph.D Scientific Co-Founder
Behrad Derakhshan Ph.D Vice President & Head of Business Development
You’re viewing 5 of 9 executives. Get the full list »

Therachon Board Members (9)

Name Representing Role Since Contact
Info
Chahra Louafi Bpifrance Board Member 000 0000
Hans Schikan Ph.D Self Non-executive Director 000 0000
Jørgen Søberg Petersen Novo Holdings Board Member 000 0000
Luca Santarelli MD Therachon Co-Founder, Chief Executive Officer & Board Member 000 0000
Michel Mencarelli Therachon Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 9 board members. Get the full list »